Am. J. Respir. Cell Mol. Biol.,
Volume 23, Number 3, September, 2000 419-426
Immunologic Characterization of Normal Human Pleural Macrophages
Marion
Frankenberger,
Bernward
Passlick,
Thomas
Hofer,
Matthias
Siebeck,
Konrad L.
Maier,
and
Löms H. W.
Ziegler-Heitbrock
Clinical Cooperation Group "Aerosols in Medicine": Institute of Inhalation Biology of the GSF National Research Center for Environment
and Health, München-Gauting; Asklepios Fachkliniken München-Gauting, Center for Pulmonology and Thoracic Surgery, Gauting;
Institute for Immunology, Ludwig-Maximilians University, Munich, Germany
Human pleural macrophages (PLM) have been studied in effusions, but little is known about normal human PLM. We therefore analyzed resting human PLM recovered by lavage before
lobe resection from patients with a central bronchial tumor,
not involving the pleura, and from patients with pulmonary
chondroma, intrapulmonary hemorrhage, and pneumothorax. Analysis of surface antigens, phagocytosis capacity, and
cytokine production was done in comparison to the regular CD14++ blood monocytes and the recently described blood
monocyte subset CD14+CD16+ monocytes. When defining fluorescence intensity for the various markers on CD14++ monocytes as 100%, the PLM gave the following pattern: CD14, 45%; CD32, 200%; CD64, 72%; CD11b, 128%; CD33, 74%;
CD54, 299%; and HLA-DR, 1,906%. When CD16 on the
CD14+CD16+ monocytes was set as 100%, the level of CD16
expression on PLM was 7.7%. Taken together, when compared to blood monocytes, PLM appear to represent a cell-type intermediate of regular CD14++ monocytes and the
CD14+CD16+ subset. In functional studies, we demonstrate
that PLM can perform efficient Fc-receptor-mediated phagocytosis of antibody-coated sheep red blood cells. Compared
with blood monocytes, the capacity of PLM to produce tumor
necrosis factor is similar, but a striking finding in PLM was the
constitutive interleukin-10 messenger RNA expression that
could not be substantially increased by lipopolysaccharide stimulation. This first characterization of normal, noneffusion human PLM can form the basis for a better interpretation of
findings in malignant and inflammatory exsudates.